# Cannabis Health Research: New Findings for June 2026 > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-health-research-new-findings-for-june-2026/ > **Published:** 2026-06-14T17:18:44-04:00 | **Last Modified / Clinically Audited:** 2026-09-09T10:07:08-04:00 > **Clinical Summary:** Clinical guide to cannabis drug interactions and bioavailability variability across formulations. Evidence-based safety for prescribers. --- ✦ New CED Clinical Relevance #47 Clinical Context Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape. ResearchSafetyDosingCBDTHCPolicyPain Why This Matters Clinicians need to understand [cannabis drug interactions](https://cedclinic.com/cannabinoid-drug-interactions-clinical-evidence/) and bioavailability variability to safely prescribe or recommend cannabis products to patients taking other medications and to set appropriate dosing expectations. The June 2026 findings likely provide updated evidence that can help standardize cannabis counseling and reduce adverse events in clinical settings. Patients benefit from clinician awareness of these pharmacological properties, which enables more informed shared decision-making about [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) and safer integration with existing treatment regimens. Dr. Caplan’s Take “We’re seeing more rigorous human studies emerge on cannabis interactions and dosing consistency, which is encouraging, but I tell my patients that bioavailability remains genuinely unpredictable across products and individuals—this is why I can’t yet give the kind of straightforward dosing guidance I can with most pharmaceuticals, and why careful monitoring matters.” Clinical Perspective 🔬 Recent [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) continues to highlight significant gaps in our understanding of drug interactions and [cannabinoid bioavailability](https://cedclinic.com/cannabis-beverage-market-united-center-partnership/), both of which have direct implications for patient safety in clinical settings. The variability in how different cannabis products are absorbed and metabolized underscores the challenge clinicians face when counseling patients about dosing consistency and potential medication interactions, particularly for patients on narrow-therapeutic-index drugs or complex polypharmacy regimens. A key caveat is that much of the emerging research stems from heterogeneous study designs and populations, making it difficult to establish generalizable clinical recommendations across diverse patient groups. Until we have more standardized data on cannabinoid pharmacokinetics and drug-drug interactions, the most practical approach for clinicians is to maintain a detailed medication history that includes all [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/), counsel patients on the unpredictability of different formulations, and consider consulting toxicology or pharmacology resources when prescribing to established cannabis 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Cannabis%20Health%20Research%3A%20New%20Findings%20for%20June%202026%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D59102)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D59102)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Cannabis%20Health%20Research%3A%20New%20Findings%20for%20June%202026%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D59102)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) Related Articles - [Don’t Sweat It: Cannabinoid CB1 Receptors Reduce Sweating in a Mouse Model](https://cedclinic.com/dont-sweat-it-cannabinoid-cb1-receptors-reduce-sweating-in-a-mouse-model/) - [Cannabis Insurance and the Fight for Patient Access | Sponsored | rutlandherald.com](https://cedclinic.com/cannabis-insurance-and-the-fight-for-patient-access-sponsored-rutlandherald-com/) - [Medical Cannabis: Demystifying the Treatment and Changing Lives #shorts](https://cedclinic.com/medical-cannabis-demystifying-the-treatment-and-changing-lives-shorts/) 📰 Source: [https://www.nugmag.com/cannabis-health-research-new-findings-for-june-2026/](https://www.nugmag.com/cannabis-health-research-new-findings-for-june-2026/) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).